Quick Answer
FENNEC PHARMACEUTICALS INC. reported Research And Development Expense of $250.0 thousand for the year ending 2025.
- FENNEC PHARMACEUTICALS INC. showed a decrease of -18.6% in Research And Development Expense from 2024 to 2025.
- This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), FENNEC PHARMACEUTICALS INC.'s Research And Development Expense has declined by 30.0%.
- Historical annual values: Fiscal year 2025: $250.0 thousand | Fiscal year 2024: $307.0 thousand | Fiscal year 2023: $56.0 thousand | Fiscal year 2022: $3.53 million | Fiscal year 2021: $4.98 million | Fiscal year 2020: $5.11 million | Fiscal year 2019: $5.61 million | Fiscal year 2018: $5.01 million | Fiscal year 2017: $1.94 million | Fiscal year 2016: $472.0 thousand | Fiscal year 2015: $256.0 thousand | Fiscal year 2014: $357.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: